Hodgkin lymphoma trials in United States

In United States 76 Also abroad 155

76 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma
Where
Basking Ridge, Commack, Duarte, Harrison, Miami, Middletown, Montvale, New York, Stanford, Uniondale
Age
18 years and over
People
257
Run by
Memorial Sloan Kettering Cancer Center
See details and how to joinNCT03618550
No phaseTaking people
Patient-Reported Outcomes and Quality of Life in Adult and Pediatric Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
Where
Aurora, Boston, Hackensack, Memphis, New York, Palo Alto, Rochester
Age
8 years and over
People
100
Run by
St. Jude Children's Research Hospital
See details and how to joinNCT06098430
Phase 2Taking people
Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
Where
Albany, Anchorage, Aurora, Baton Rouge, Boise, Boston, Chattanooga, Clovis, East Syracuse, Eugene, Fairfax, Fullerton, Gainesville, Glendale, Grand Rapids, Lexington, Los Angeles, Miami, Nashville, Omaha, Orlando, Panorama City, Portland, San Francisco, Swansea, Tacoma, Temple, The Woodlands, Torrance, Tyler, Virginia Beach, Waukee
Age
18 years and over
People
130 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT06806033 · EU 2024-516791-15-00
Phase 1/2Taking people
A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
Where
Cleveland, Denver, Los Angeles, Nashville
Age
18 years and over
People
280 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT07519772 · EU 2025-523005-15-00
No phaseTaking people
Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols
Where
Bethesda
Age
18 years to 120 years
People
500
Run by
National Cancer Institute (NCI)
See details and how to joinNCT02682667
Phase 2Taking people
Auto Stem Cell Transplant for Lymphoma Patients
Where
Minneapolis
Age
Up to 75 years
People
150
Run by
Masonic Cancer Center, University of Minnesota
See details and how to joinNCT03125642
Phase 1Taking people
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
Where
Athens, Birmingham, Boston, Buffalo, Fort Wayne, Margate, Nashville, Orlando, Palo Alto, Sarasota, Spokane
Age
18 years and over
People
85
Run by
Compass Therapeutics
See details and how to joinNCT06150664
Phase 1Taking people
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
Where
Atlanta, Boston, Columbus, Dallas, Denver, Duarte, Houston, Los Angeles, Miami, Milwaukee, Nashville, New York, Portland, Rochester, San Francisco, Sarasota, Scottsdale, Seattle
Age
18 years and over
People
460 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07226843 · EU 2025-523601-16-00
Phase 2Taking people
Personalized NK Cell Therapy in CBT
Where
Houston
Age
15 years to 80 years
People
100
Run by
M.D. Anderson Cancer Center
See details and how to joinNCT02727803
Phase 1/2Taking people
Nivolumab With Ruxolitinib in Relapsed or Refractory Classical Hodgkin Lymphoma
Where
Chicago, Columbus, Indianapolis, Iowa City, Madison, Minneapolis
Age
18 years and over
People
54
Run by
Veronika Bachanova
See details and how to joinNCT03681561
Phase 1Taking people
A Study of ARC-02 in B-cell NHL
Where
Charlotte, Los Angeles, Louisville, Milwaukee, Richmond, Spokane
Age
18 years and over
People
140 worldwide
Run by
Taiho Oncology, Inc.
See details and how to joinNCT07691606 · EU 2026-525606-35-00
No phaseTaking people
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Where
Atlanta, Aurora, Cincinnati, Houston, Milwaukee, Philadelphia
Age
0 years to 38 years
People
30
Run by
Children's Hospital Medical Center, Cincinnati
See details and how to joinNCT06131801
No phaseTaking people
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Where
Chapel Hill
Age
18 years to 120 years
People
15,000
Run by
UNC Lineberger Comprehensive Cancer Center
See details and how to joinNCT01137643
Phase 1Taking people
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
Where
Madison
Age
7 months to 21 years
People
22
Run by
University of Wisconsin, Madison
See details and how to joinNCT02508038
No phaseTaking people
Tissue Collection for Studies of Lymph Cancer
Where
Bethesda
Age
18 years and over
People
1,295 worldwide
Run by
National Cancer Institute (NCI)
See details and how to joinNCT01676805
Phase 2Taking people
AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion
Where
Valhalla
Age
1 day to 30 years
People
20
Run by
Mitchell Cairo
See details and how to joinNCT04099966
Phase 2Taking people
CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant
Where
Atlanta, Boston, Duarte
Age
18 years to 75 years
People
216
Run by
City of Hope Medical Center
See details and how to joinNCT06059391
Phase 1Taking people
A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
Where
Atlanta, Boston, Duarte
Age
18 years to 75 years
People
46
Run by
City of Hope Medical Center
See details and how to joinNCT07020533
No phaseEnrolling by invitation
Biology Studies of Hematologic Cancers
Where
Bethesda
Age
1 year to 120 years
People
550
Run by
National Cancer Institute (NCI)
See details and how to joinNCT00923442
Phase 3Taking people
Wisconsin Ginseng for Decreasing Cancer Related Fatigue
Where
Albert Lea, Bemidji, Brainerd, Deer River, Detroit Lakes, Duluth, Fosston, Hibbing, Mankato, Monticello, Rochester, Sandstone, Thief River Falls, Virginia, Worthington
Age
18 years and over
People
222
Run by
Mayo Clinic
See details and how to joinNCT06395441
Phase 2Taking people
ctDNA-Guided Therapy for Relapsed/Refractory Hodgkin Lymphoma
Where
Davis, Fresno, Irvine, La Jolla, Los Angeles, San Francisco
Age
18 years and over
People
38
Run by
Michael Spinner, MD
See details and how to joinNCT07021989
Phase 2Taking people
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
Where
Austin, Charlotte, Chicago, Columbus, Duarte, Houston, Iowa City, Jacksonville, Milwaukee, Nashville, New Brunswick, New York, Overland Park, Philadelphia, Phoenix, Pittsburgh, Portland, Rochester, San Antonio, St Louis, Tampa, Waukee
Age
18 years and over
People
270 worldwide
Run by
AstraZeneca
See details and how to joinNCT06526793 · EU 2023-505789-27-00
No phaseTaking people
Establishing a Tumor Bank in Families With Multiple Lymphoproliferative Malignancies
Where
Boston
Age
18 years and over
People
1,500
Run by
Dana-Farber Cancer Institute
See details and how to joinNCT00131014
Phase 1/2Taking people
AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
Where
Atlanta, Boston, Duarte, Houston, Miami, New York, Philadelphia
Age
12 years and over
People
161 worldwide
Run by
AstraZeneca
See details and how to joinNCT06137144 · EU 2023-506747-42-00
Phase 1Taking people
A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)
Where
Aurora, Chicago, Cincinnati, Los Angeles, Palo Alto, Philadelphia, Salt Lake City, San Antonio, Seattle
Age
0 years to 18 years
People
30 worldwide
Run by
Autolus Limited
See details and how to joinNCT06173518 · EU 2023-506307-26-00